Course of Esophageal Candidiasis and Outcomes of Patients at a Single Center

Patrick Hoversten, Fouad Otaki, David A Katzka

Research output: Contribution to journalShort survey

4 Scopus citations

Abstract

Candida infection in the gastrointestinal tract is most studied in immunocompromised patients. Patients without systemic immunodeficiency, however, may have esophageal candidiasis associated with antibiotic or steroid medication use, alcoholic consumption, diabetes mellitus, and esophageal stasis disorders such achalasia or scleroderma esophagus.1–5 This population has not been well studied. We aim to describe demographics, risk factors, and relevant clinical outcomes for patients with Candida esophagitis with an emphasis in systemically immunocompetent patients.

Original languageEnglish (US)
Pages (from-to)200-202.e1
JournalClinical Gastroenterology and Hepatology
Volume17
Issue number1
DOIs
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Course of Esophageal Candidiasis and Outcomes of Patients at a Single Center'. Together they form a unique fingerprint.

  • Cite this